BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31169451)

  • 1. Mesoporous gold nanoparticles for photothermal controlled anticancer drug delivery.
    Zhang L; Shen S; Cheng L; You H; Lu L; Ma C; Dai Y; Fang J
    Nanomedicine (Lond); 2019 Jun; 14(11):1443-1454. PubMed ID: 31169451
    [No Abstract]   [Full Text] [Related]  

  • 2. Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy.
    Feng S; Mao Y; Wang X; Zhou M; Lu H; Zhao Q; Wang S
    J Colloid Interface Sci; 2020 Feb; 559():51-64. PubMed ID: 31610305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold nanoparticles modified hollow carbon system for dual-responsive release and chemo-photothermal synergistic therapy of tumor.
    Zhao Q; Yang Y; Wang H; Lei W; Liu Y; Wang S
    J Colloid Interface Sci; 2019 Oct; 554():239-249. PubMed ID: 31301524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Assembled Upconversion Nanoparticle Clusters for NIR-controlled Drug Release and Synergistic Therapy after Conjugation with Gold Nanoparticles.
    Cai H; Shen T; Kirillov AM; Zhang Y; Shan C; Li X; Liu W; Tang Y
    Inorg Chem; 2017 May; 56(9):5295-5304. PubMed ID: 28402112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous silica-coated gold nanoframes as drug delivery system for remotely controllable chemo-photothermal combination therapy.
    Gao Z; Shi T; Li Y; You C; Cheng K; Sun B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():230-238. PubMed ID: 30623810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facile Construction of i-Motif DNA-Conjugated Gold Nanostars as Near-Infrared and pH Dual-Responsive Targeted Drug Delivery Systems for Combined Cancer Therapy.
    Miao D; Yu Y; Chen Y; Liu Y; Su G
    Mol Pharm; 2020 Apr; 17(4):1127-1138. PubMed ID: 32092274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of Raman tag-bridged core-shell Au@Cu
    He J; Dong J; Hu Y; Li G; Hu Y
    Nanoscale; 2019 Mar; 11(13):6089-6100. PubMed ID: 30869726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylated graphene oxide-capped gold nanorods/silica nanoparticles as multifunctional drug delivery platform with enhanced near-infrared responsiveness.
    Qi Z; Shi J; Zhang Z; Cao Y; Li J; Cao S
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109889. PubMed ID: 31499943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
    Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined chemo/photothermal therapy based on mesoporous silica-Au core-shell nanoparticles for hepatocellular carcinoma treatment.
    Wang J; Zhang Y; Liu L; Cui Z; Liu X; Wang L; Li Y; Li Q
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1487-1495. PubMed ID: 31172835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailored Covalent Organic Framework Platform: From Multistimuli, Targeted Dual Drug Delivery by Architecturally Engineering to Enhance Photothermal Tumor Therapy.
    Rahmani Khalili N; Banitalebi Dehkordi A; Amiri A; Mohammadi Ziarani G; Badiei A; Cool P
    ACS Appl Mater Interfaces; 2024 Jun; 16(22):28245-28262. PubMed ID: 38770930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photothermally controlled drug release system with high dose loading for synergistic chemo-photothermal therapy of multidrug resistance cancer.
    Wu X; Liu J; Yang L; Wang F
    Colloids Surf B Biointerfaces; 2019 Mar; 175():239-247. PubMed ID: 30540971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-infrared triggered co-delivery of doxorubicin and quercetin by using gold nanocages with tetradecanol to maximize anti-tumor effects on MCF-7/ADR cells.
    Zhang Z; Xu S; Wang Y; Yu Y; Li F; Zhu H; Shen Y; Huang S; Guo S
    J Colloid Interface Sci; 2018 Jan; 509():47-57. PubMed ID: 28881205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments.
    Park H; Yang J; Lee J; Haam S; Choi IH; Yoo KH
    ACS Nano; 2009 Oct; 3(10):2919-26. PubMed ID: 19772302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designed Synthesis of Au/Fe
    Zhang Q; Zhang L; Li S; Chen X; Zhang M; Wang T; Li L; Wang C
    Chemistry; 2017 Dec; 23(68):17242-17248. PubMed ID: 28845884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hollow-structured nanohybrid: Intelligent and visible drug delivery and photothermal therapy for cancer.
    Yang L; Hu B; Liu AH; Zhang Y
    Talanta; 2020 Aug; 215():120893. PubMed ID: 32312438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A NIR light-triggered drug delivery system using core-shell gold nanostars-mesoporous silica nanoparticles based on multiphoton absorption photo-dissociation of 2-nitrobenzyl PEG.
    Hernández-Montoto A; Gorbe M; Llopis-Lorente A; Terrés JM; Montes R; Cao-Milán R; Díaz de Greñu B; Alfonso M; Orzaez M; Marcos MD; Martínez-Máñez R; Sancenón F
    Chem Commun (Camb); 2019 Aug; 55(61):9039-9042. PubMed ID: 31292589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold nanoparticle-gated mesoporous silica as redox-triggered drug delivery for chemo-photothermal synergistic therapy.
    Yang Y; Lin Y; Di D; Zhang X; Wang D; Zhao Q; Wang S
    J Colloid Interface Sci; 2017 Dec; 508():323-331. PubMed ID: 28843922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-conversion nanoparticle assembled mesoporous silica composites: synthesis, plasmon-enhanced luminescence, and near-infrared light triggered drug release.
    Niu N; He F; Ma P; Gai S; Yang G; Qu F; Wang Y; Xu J; Yang P
    ACS Appl Mater Interfaces; 2014 Mar; 6(5):3250-62. PubMed ID: 24521281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIR Light-Activated Drug Release for Synergetic Chemo-Photothermal Therapy.
    Yuan A; Huan W; Liu X; Zhang Z; Zhang Y; Wu J; Hu Y
    Mol Pharm; 2017 Jan; 14(1):242-251. PubMed ID: 27983855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.